EQ-5D-3L trials | SF-6D trial | |||||||
---|---|---|---|---|---|---|---|---|
% at floor | % at ceiling | % at floor | % at ceiling | |||||
Baseline | 24 weeksb | Baseline | 24 weeksb | Baseline | 24 weeksb | Baseline | 24 weeksb | |
N | 997 | 951 | 997 | 951 | 441 | 441 | 416 | 416 |
CFQ-R-8D | ||||||||
CFQ-R-8D utility | 0.00 | 0.00 | 1.70 | 3.68 | 0.00 | 0.00 | 1.81 | 3.85 |
Physical Functioning | 0.70 | 1.89 | 72.42 | 69.09 | 1.36 | 2.16 | 63.04 | 64.18 |
Role Functioning | 0.90 | 2.52 | 73.62 | 69.93 | 1.81 | 1.20 | 70.29 | 74.52 |
Emotion | 1.00 | 0.63 | 39.92 | 50.37 | 0.91 | 1.20 | 40.36 | 45.67 |
Vitality | 1.50 | 1.47 | 37.61 | 40.48 | 1.81 | 1.92 | 41.72 | 42.55 |
Breathing Difficulty | 0.70 | 0.32 | 53.86 | 52.68 | 0.23 | 0.72 | 51.93 | 57.69 |
Cough | 10.53 | 9.67 | 5.22 | 10.09 | 9.30 | 8.17 | 4.31 | 6.73 |
Abdominal Pain | 0.60 | 0.74 | 59.58 | 58.99 | 0.68 | 1.20 | 53.74 | 53.37 |
Body Image | 1.20 | 1.26 | 64.19 | 64.25 | 1.36 | 1.92 | 64.63 | 62.74 |
EQ-5D-3L | ||||||||
EQ-5D-3L utility | 0.00 | 0.00 | 60.88 | 62.36 | – | – | – | – |
Mobility | 0.00 | 0.00 | 95.39 | 93.06 | – | – | – | – |
Self-care | 0.00 | 0.11 | 99.70 | 99.37 | – | – | – | – |
Usual activities | 0.10 | 0.21 | 88.37 | 85.59 | – | – | – | – |
Pain/discomfort | 0.40 | 0.74 | 73.62 | 75.81 | – | – | – | – |
Depression/anxiety | 0.40 | 0.42 | 80.74 | 81.49 | – | – | – | – |
SF-6D | ||||||||
SF-6D utility | – | – | – | – | 0.00 | 0.00 | 5.44 | 8.65 |
Physical functioning | – | – | – | – | 8.16 | 7.71 | 55.56 | 61.20 |
Role limitation | – | – | – | – | 23.81 | 22.84 | 48.53 | 52.64 |
Social functioning | – | – | – | – | 0.68 | 0.24 | 63.04 | 64.90 |
Pain | – | – | – | – | 0.45 | 0.72 | 74.15 | 73.08 |
Mental health | – | – | – | – | 0.68 | 0.24 | 55.33 | 58.17 |
Energy | – | – | – | – | 5.44 | 5.53 | 7.48 | 10.10 |
CFRSD | – | – | – | – | 0.00 | 0.00 | 1.81 | 3.85 |